Effective Surveillance
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Officers at authorities, ministries, international organisations and NGO’s who wish to prevent the further global spreading of Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Senior officials and (top) civil servants at national authorities
- Policy Officers at Ministries
- Civil servants at regional authorities
- Senior officials at international organizations
- Senior officials at NGO’s
Latest Topics
-
15 September 2025Strengthening antimicrobial resistance surveillance across African military settings
This paper highlights the overlooked role of military health systems in AMR surveillance in Africa. Military personnel face high risks of drug-resistant infections due to combat injuries, overcrowding, and poor sanitation, yet national AMR strategies largely focus on civilian systems. As a result, AMR trends in military populations and conflict zones are poorly documented. The […]
Read more... -
15 September 2025Investigating the know-do gap in antibiotics prescribing: Experimental evidence from India
This study shows that antibiotic overprescribing for pediatric diarrhea in India is mainly driven by a “know-do gap” rather than lack of medical knowledge. While 70% of providers prescribed antibiotics without indication, 62% did so despite knowing it was inappropriate. Eliminating this gap could reduce unnecessary prescribing by 30 percentage points, compared to just 6 […]
Read more... -
12 September 2025Survey on the epidemiological situation, laboratory capacity and preparedness for Candidozyma (Candida) auris, 2024
The 2024 ECDC survey shows that Candidozyma (Candida) auris is rapidly emerging in Europe, with 4,012 cases reported in EU/EEA countries between 2013–2023, including 1,346 in 2023 alone, and additional cases in enlargement countries. While 10 countries have not yet detected the pathogen, others such as Spain, Italy, Greece, and Romania already face regional endemicity, […]
Read more...
More news related to Effective surveillance
